Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Definitive Chemoradiation With Elective Nodal Irradiation Dose De-escalation for p16 Positive Squamous Cell Carcinoma of the Oropharynx "ENID"

NCT04444869 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT04444869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04444869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Definitive Chemoradiation With Elective Nodal Irradiation Dose De-escalation for p16 Positive Squamous Cell Carcinoma of the Oropharynx "ENID"
Lead sponsor
University of Missouri-Columbia
Phase
Phase 2
Overall status
Unknown status
Start date
September 28, 2020
Completion date
June 30, 2026
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the head and neck, hpv positive oropharyngeal squamous cell carcinoma, oropharynx cancer, throat carcinoma